• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORATION LIPOSORBER LA-15 SYSTEM; APHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORATION LIPOSORBER LA-15 SYSTEM; APHERESIS SYSTEM Back to Search Results
Model Number LA-15
Device Problem No Apparent Adverse Event (3189)
Patient Problem Unspecified Kidney or Urinary Problem (4503)
Event Date 04/20/2022
Event Type  Injury  
Event Description
The patient's fifth liposorber treatment was completed on (b)(6) 2022.The site reported no device issues or complications during treatment.The patient was hospitalized from (b)(6) 2022 to (b)(6) 2022 due to acute kidney injury and was released when recovered.Patient also was reported to have shortness of breath and chest pain which were assessed as not related to liposorber treatment by the physician.The acute kidney injury relationship to treatment with liposorber was assessed as unknown.However, the physician has continuing the patient on liposorber treatments.
 
Manufacturer Narrative
Possible causes of the problem: no equipment or other problems occurred during treatment.From the patient's history, we infer the possibility that this was not an adverse reaction related to the device in question, but rather an aggravation of a pre-existing condition; however, from 'the information obtained, a causal relationship could not reasonably be ruled out.Conclusion: as a result of the investigation, the cause of the failure could not be identified.The number and frequency of past occurrences similar to the said defects are as follows during the past three years (may 2019 to end of april 2022), there have been two cases (including this case) reported concerning health hazards similar to the case in question.Number of shipments of the product in question the total number of shipments during the above period was 67,603 boxes (domestic and export).Frequency of occurrence: 0.003% (2 cases/67,603 boxes).Mfr report #: 3002808904-2022-00011.
 
Event Description
See initial report - no changes.
 
Manufacturer Narrative
Investigation: no similar complaint has been reported by other facilities or customers until now.Conclusion: no abnormality was found in manufacturing and quality control records.In this case, we could not identify the cause of the adverse events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
APHERESIS SYSTEM
Manufacturer (Section D)
KANEKA CORPORATION
5-1-1, torikai-nishi,
osaka city, osaka 530-8 288
JA  530-8288
MDR Report Key15312087
MDR Text Key298802140
Report Number2435151-2022-00001
Device Sequence Number1
Product Code PBN
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 08/29/2022,09/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberLA-15
Device Catalogue NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA08/29/2022
Distributor Facility Aware Date04/28/2022
Event Location Outpatient Treatment Facility
Date Report to Manufacturer08/29/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age61 YR
Patient SexMale
Patient Weight91 KG
-
-